Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Asia Update: U.S. Queries Looming Japanese Reforms, Korean Bill In Works

This article was originally published in The Gray Sheet

Executive Summary

Improved review times are a necessary pre-condition of Japan's nascent user free program if the Ministry of Health, Labor and Welfare expects U.S. firms to comply with the initiative, according to AdvaMed

You may also be interested in...



Japan Device Pricing To Benefit From Hospital Efficiency Incentives

The Ministry of Health, Labor & Welfare in Japan will offer hospitals a 15% bonus payment for reducing the time patients remain in the inpatient setting, provided the centers fall within the top length-of-stay quartile

Japan Device Pricing To Benefit From Hospital Efficiency Incentives

The Ministry of Health, Labor & Welfare in Japan will offer hospitals a 15% bonus payment for reducing the time patients remain in the inpatient setting, provided the centers fall within the top length-of-stay quartile

Global Device Market Barriers, Strategies Detailed For U.S. Trade Report

Increased medical equipment import tariffs of up to 51% within India's 2002-2003 budget will add millions of dollars in costs for U.S. device companies, AdvaMed asserts in a Dec. 13 statement to the Office of the U.S. Trade Representative

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017515

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel